US3654924A - Blood collection assembly - Google Patents

Blood collection assembly Download PDF

Info

Publication number
US3654924A
US3654924A US37205A US3654924DA US3654924A US 3654924 A US3654924 A US 3654924A US 37205 A US37205 A US 37205A US 3654924D A US3654924D A US 3654924DA US 3654924 A US3654924 A US 3654924A
Authority
US
United States
Prior art keywords
tubing
blood
frangible portion
pouch
assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US37205A
Inventor
Earl D Wilson
Norbert W Ellmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of US3654924A publication Critical patent/US3654924A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • A61J1/12Bag-type containers with means for holding samples of contents

Definitions

  • ABSTRACT Disclosed herein is a blood collection assembly including an auxiliary sample pouch with a pass-through tube for filling the blood bag.
  • the pass-through tube is the same diameter as the remaining tubing of the assembly and is frangible within the pouch so that the tubing can be placed in communication with the pouch.
  • This invention relates to a blood collection assembly and particularly to an assembly that includes a blood bag and tubing connected to the blood bag with an auxiliary sample pouch in line with the tubing.
  • a number of devices are presently available to deal with the problem of collecting, handling and storage of whole blood or other fluid donations. And while several such devices have considered the generic idea of a primary storage bag to contain the bulk of the donation with an auxiliary sample pouch for segregating a sample of the donation for tests, etc.; the prior art devices designed as a solution to the generic problem have not been totally acceptable or free from problems.
  • the most common of these prior art devices includes a phlebotomy needle connected through tubing to one end of a sample pouch.
  • the tubing is connected to the opposite end of the sample pouch and communicates the sample pouch with a blood bag.
  • blood from the donor passes through the first tubing, the sample pouch and then through the second tubing into the blood bag.
  • the tubing closest to the bag is clamped off.
  • the sample pouch is allowed to fill with blood and then the tubing closest to the donor is clamped OE and the needle is withdrawn from the patient.
  • the sealed sample pouch is then removed by cutting the tubing on either side thereof and a sample of the blood just collected is thus provided for testing purposes.
  • the blood bag provided in the system normally contains an anti-coagulant which helps to preserve the collected blood during storage.
  • This anti-coagulant before the bag is used to collect blood is free to flow through the tubing and into the sample pouch.
  • the anti-coagulant is necessary to preserve the collected blood, it can be considered a contaminate of the sample of blood which is collected in the pouch for testing.
  • Another problem associated with these prior art type devices is the large change in diameter of the passage for the blood when the blood travels through the small diameter tubing into the large diameter sample pouch and then back into the small diameter tubing before entering the blood bag.
  • the varying diameter between the tubing and the sample pouch causes a turbulent flow path for the blood which increases the chance that some of the blood will coagulate within the pouch.
  • the present invention is designed to obviate these and other problems associated with the prior art devices and includes in its most elementary form a sample pouch sealed about a continuous tubing passing from the phlebotomy needle to the blood bag with a frangible section provided in the tubing interior of the encapulating sample pouch.
  • the blood collection assembly of this invention is first removed from its shipment package and the phlebotomy needle is inserted in the donors vein.
  • the blood then flows through the tubing of the assembly into the blood bag and when the flood bag is filled, it is isolated from the system by a clamp or tying of the tubing.
  • the frangible section of the tubing interior of the encapulating sample pouch is broken so that the blood will flow into the pouch.
  • the tubing between the pouch and the phlebotomy needle is clamped off and a sample of the donation is thus provided.
  • one of the primary objects of this invention is to provide a blood collection assembly which insures a constant diameter flow path of the blood from the donor to the blood bag and which assembly further permits the collection of a sample of the donation after the blood bag is filled.
  • Still another primary object of this invention is to provide an assembly of the type just described with a frangible section in the tubing encapulated by the sample pouch so that the sample pouch may be placed in communication with the feed tube after the blood bag is filled.
  • Fig. 1 is a schematic perspective of the basic system
  • FIG. 2 is a blow-up partially in cross-section of the portion of the system including the sample pouch
  • F IG. 3 is a blow-up partially in cross-section of a second embodiment of the invention including the portion of the system having the sample pouch, and
  • FIG. 4 is a yet another embodiment of the invention showing features comparable to those features shown in FIGS. 2 and 3.
  • the system can be seen to include a phlebotomy needle 10 for insertion into a vein of the donor.
  • a phlebotomy needle 10 for insertion into a vein of the donor.
  • the feed tube 12 Connected to the hub of the needle 10 is the feed tube 12.
  • the blood bag 14 Connected to the opposite end of the feed tube 12 is the blood bag 14.
  • a frangible portion indicated generally at 20 is Intermediate the initial end 16 and the terminal end 18 of the tube 12.
  • Encapsulating the segment of the feed tube 12 including the frangible portion 20 is the sample pouch 22 which is sealed at end walls about the outside diameter of the feed tube 12 at 24 where the tube enters the pouch and at 26 where the tube exits from the pouch.
  • the first step in the use of the blood collection assembly of the present invention would be to remove the assembly from its shipment package (not shown) and mount the blood bag on a suitable standard. The phlebotomy needle is then inserted in the donors vein and passage of the blood will proceed immediately through the feed tube 12 and directly into the blood bag 14.
  • the packaged assembly will normally include a standard anti-coagulant in the blood bag and that during shipment, some of the anti-coagulant will possibly drain into the feed tube 12. However, with the initial in rush of blood through the tube 12, the anti-coagulant will be swept back into the blood bag 14 where it operates in its desired capacity to prevent coagulation of the donation during storage and shipment.
  • the tubing 12 from its initial end to its terminal end is of a substantially constant diameter and it is essential that no abrupt changes in the diameter of the tubing be present.
  • the substantially constant diameter of the tube 12 throughout its entire length insures a laminae flow of the blood from the donor to the bag 14 and avoids any turbulence in the flow which would tend to result in coagulation. This is particularly true when the blood is passing through the pouch 22 since in the initial use of the system, the pouch 22 acts merely to encapsulate the tubing 12 and the smooth flow of the blood through the pouch is uninterrupted during the period in which the donation is collected.
  • the bag, pouch and possibly the tubing will be collapsed and air will have been expelled from at least a major portion of the system.
  • This condition of the system may be insured by either the construction of the bag and pouch to have basically a flat or sandwich type construction so that a minor amount of interior space will initially be presented, or, on the other hand, the system may be connected to a vacuum source and completely collapsed with a clamp placed on the feed tube 12 adjacent the initial end 16 and which clamp is removed only after the phlebotomy needle 16 has been inserted in the donors vein.
  • the purpose of insuring that air is expelled from the system initially is to avoid the need for a vent port or the like to which air may escape when a volume of air that would otherwise be within the bag or pouch is displaced by the inrushing blood. If the bag is collapsed initially so as to avoid having any air in the chamber thereof, the flexible bag or pouch will deform in response to the incoming blood in order to provide a sufficient volume within its chamber to accomodate the donation and/or sample.
  • the blood bag 14 is isolated from the system by either providing a clamp on the segment of tube 28 or tying off the tube at the section 28 in any convenient manner.
  • the frangible portion 20 within the flexible pouch 22 is broken so as to place the passage of the tube 12 in communication with the chamber 30 formed interior of the sample pouch 22. Since the pouch 22 is sealed to the outside diameter of the tube 12 at points 24 and 26, the interior side walls of the pouch form a collection chamber surrounding the tubing in which may be collected a sample of the donation being offered.
  • the section 32 of the tubing 12 is clamped or sealed off in any desired manner and the needle is removed from the donor.
  • the sealed sample pouch is then removed from the system by cutting the tubing and a sample of the blood just collected is thus provided for testing purposes.
  • This sample is exactly representative of the donation just collected and is obtained with a minimum of coagulation and at the same time contamination of the sample by any of the anti-coagulate in the system is prevented.
  • the frangible portion 20 is shown as either a hardened or weakened segment 34 in the line of the tube 12 between the sections 32 and 28. Since the pouch 22 is of a flexible and preferably transparent material, once the blood bag 14 has been filled, it will merely be necessary to grasp the sections 28 and 32 and break the tube 12 at the point 34 in order to place the passage of the tube 12 in communication with the chamber 30.
  • the frangible portion 20 of this embodiment is shown to include a sleeve 40 connecting the two sections 28 and 32 of the tube 12.
  • a sleeve 40 connecting the two sections 28 and 32 of the tube 12.
  • the frangible portion 20 includes the relatively rigid sleeve 42.
  • the sleeve 42 is counterbored at 44 and 46 for receiving the sections 32 and 28, respectively, of the tubing 12.
  • the central portion 48 of the sleeve 42 is of the same inside diameter as the tube 12 and the counterbores 44 and 46 are of the same outside diameter as the tube 12 so that a substantially constant diameter passage is provided for the blood flowing from the donor to the bag 14 and laminae flow of the blood is insured.
  • This laminae flow is also insured in the embodiment shown in FIGS. 2 and 3 due to the substantially constant inside diameter of the tubing as is apparent from the drawings.
  • the central portion 48 of the sleeve 42 is weakened at 50, and once the bag 14 has been filled and isolated from the system by the clamping procedure previously described, it is merely necessary to grasp the two ends of the sleeve 42 on either side of the central portion 48 and snap the frangible member at the point 50. This rupture of the sleeve 42 places the passage of the tube 12 in communication with the chamber 30 of the pouch 22 so that the sample may be collected.
  • a blood collection assembly including a needle for inserting in a donors vein, a bag for collection of the donation, and tubing having an initial end and a terminal end, said tubing connected to said needle at said initial end and to said bag at said terminal end, the improvement comprising: said tubing having a passageway therethrough of substantially constant inside diameter from said initial end to said terminal end to insure laminar flow of blood through said tubing and avoid turbulent flow at any point along said passageway, said tubing having a frangible portion intermediate said initial and terminal ends, and a closed sample pouch encapsulating said frangible portion and having end walls sealed to said tubing on either side of said frangible portion, said pouch including an empty chamber formed about the continuous length of said tubing including said frangible portion, said frangible portion being disposed intermediate, but spaced from, said end walls.
  • tubing includes a first section communicating with said initial end and a second section communicating with said terminal end, and said frangible portion includes a sleeve holding said first and second sections of said tubing in abutting engagement.
  • said tubing includes a first section communicating with said initial end and a second section communication with said terminal end
  • said frangible portion includes a hardened sleeve having a weakened central section, counterbored end sections and shoulders interconnecting said central sections and said end sections, the inside diameter of the central section being substantially constant and equal to the inside diameter of said tubing, the inside diameter of said end sections being substantially equal to the outside diameter of said tubing and said first and second sections of said tubing fitted within said end sections and abutting said shoulders.
  • a method of collecting blood from a donor which includes placing tubing in communication with a donor source, passing blood through said tubing in a laminar flow pattern from said cource to a collection point, collecting a donation of blood at said collection point, interrupting said laminar flow pattern intermediate said source and said collection point, and collecting a sample of blood in a pouch having a first end wall sealed to the tubing upstream of the point of interruption of said flow pattern and a second end wall sealed to the tubing downstream of the point of interruption of said flow pattern said pouch having side walls surrounding said tubing to define a chamber for collecting the sample of blood.

Abstract

Disclosed herein is a blood collection assembly including an auxiliary sample pouch with a pass-through tube for filling the blood bag. The pass-through tube is the same diameter as the remaining tubing of the assembly and is frangible within the pouch so that the tubing can be placed in communication with the pouch.

Description

United States Patent Wilson et al.
[151 3,654,924 [451 Apr. 11, 1972 [54] BLOOD COLLECTION ASSEMBLY [72] Inventors:
mann, Libertyville, both of 111.
Abbott Laboratorles, North Chicago, 111.
May 14. 1970 Assigncc:
Filed:
Appl. No.;
Earl D. Wilson, lngleside; Norbert W. E11- References Cited UNITED STATES PATENTS 3,467,095 9/1969 Ross ..l28/2l4.2
Int. Cl. ..A6lm 05/14 Field of Search 123/214, 214.2, 272, 276, 278,
3,064,647 11/1962 Earl ..l28/272 X 3,217,710 ll/l965 ..l28/2l4.2 3,342,179 9/1967 Ellman ..128/214.2 3,127,892 4/1964 Bellamy et al. ..l28/2l4.2 2,955,595 10/1960 Semple 1 28/214 2,950,716 8/1960 Bellamy et al. ..l28/2l4 Primary Examiner-- Dalton L. Truluck Attorney-Sherman and Shalloway [57] ABSTRACT Disclosed herein is a blood collection assembly including an auxiliary sample pouch with a pass-through tube for filling the blood bag. The pass-through tube is the same diameter as the remaining tubing of the assembly and is frangible within the pouch so that the tubing can be placed in communication with the pouch.
12 Claims, 4 Drawing Figures PATENTEDAPR 11 I972 FIG. 1
BLOOD COLLECTION ASSEMBLY This invention relates to a blood collection assembly and particularly to an assembly that includes a blood bag and tubing connected to the blood bag with an auxiliary sample pouch in line with the tubing.
A number of devices are presently available to deal with the problem of collecting, handling and storage of whole blood or other fluid donations. And while several such devices have considered the generic idea of a primary storage bag to contain the bulk of the donation with an auxiliary sample pouch for segregating a sample of the donation for tests, etc.; the prior art devices designed as a solution to the generic problem have not been totally acceptable or free from problems.
The most common of these prior art devices includes a phlebotomy needle connected through tubing to one end of a sample pouch. The tubing is connected to the opposite end of the sample pouch and communicates the sample pouch with a blood bag. With this device, blood from the donor passes through the first tubing, the sample pouch and then through the second tubing into the blood bag. When the blood bag is full, the tubing closest to the bag is clamped off. At this point, the sample pouch is allowed to fill with blood and then the tubing closest to the donor is clamped OE and the needle is withdrawn from the patient. At this point, the sealed sample pouch is then removed by cutting the tubing on either side thereof and a sample of the blood just collected is thus provided for testing purposes.
A number of problems are associated with this type of system. First of all, the blood bag provided in the system normally contains an anti-coagulant which helps to preserve the collected blood during storage. This anti-coagulant, before the bag is used to collect blood is free to flow through the tubing and into the sample pouch. Although the anti-coagulant is necessary to preserve the collected blood, it can be considered a contaminate of the sample of blood which is collected in the pouch for testing. Another problem associated with these prior art type devices is the large change in diameter of the passage for the blood when the blood travels through the small diameter tubing into the large diameter sample pouch and then back into the small diameter tubing before entering the blood bag. The varying diameter between the tubing and the sample pouch causes a turbulent flow path for the blood which increases the chance that some of the blood will coagulate within the pouch.
The present invention is designed to obviate these and other problems associated with the prior art devices and includes in its most elementary form a sample pouch sealed about a continuous tubing passing from the phlebotomy needle to the blood bag with a frangible section provided in the tubing interior of the encapulating sample pouch. With a device of this type, it is thus possible to prevent the anti-coagulant from entering the sample pouch prior to use of the collection assembly and moreover, during use of the collection assembly of the present invention, the blood from the donor flows through a constant diameter tubing to the blood bag so as to avoid turbulent flow and the resultant detrimental coagulation within the sample pouch.
In use, the blood collection assembly of this invention is first removed from its shipment package and the phlebotomy needle is inserted in the donors vein. The blood then flows through the tubing of the assembly into the blood bag and when the flood bag is filled, it is isolated from the system by a clamp or tying of the tubing. Next, the frangible section of the tubing interior of the encapulating sample pouch is broken so that the blood will flow into the pouch. Once the pouch is filled, the tubing between the pouch and the phlebotomy needle is clamped off and a sample of the donation is thus provided.
From this brief description of the prior art and summary of the invention, it would be apparent that one of the primary objects of this invention is to provide a blood collection assembly which insures a constant diameter flow path of the blood from the donor to the blood bag and which assembly further permits the collection of a sample of the donation after the blood bag is filled.
Still another primary object of this invention is to provide an assembly of the type just described with a frangible section in the tubing encapulated by the sample pouch so that the sample pouch may be placed in communication with the feed tube after the blood bag is filled.
Some of the primary objects of the invention having been stated, other objects attending this invention will become apparent to those of skill in the art when consideration is given to the following detailed description of an exemplary embodiment. This description is made in conjunction with the accompanying drawings wherein:
Fig. 1 is a schematic perspective of the basic system,
FIG. 2 is a blow-up partially in cross-section of the portion of the system including the sample pouch,
F IG. 3 is a blow-up partially in cross-section of a second embodiment of the invention including the portion of the system having the sample pouch, and
FIG. 4 is a yet another embodiment of the invention showing features comparable to those features shown in FIGS. 2 and 3.
Referring now to FIG. 1, the system can be seen to include a phlebotomy needle 10 for insertion into a vein of the donor. Connected to the hub of the needle 10 is the feed tube 12. Connected to the opposite end of the feed tube 12 is the blood bag 14. Intermediate the initial end 16 and the terminal end 18 of the tube 12 is a frangible portion indicated generally at 20.
Encapsulating the segment of the feed tube 12 including the frangible portion 20 is the sample pouch 22 which is sealed at end walls about the outside diameter of the feed tube 12 at 24 where the tube enters the pouch and at 26 where the tube exits from the pouch.
The first step in the use of the blood collection assembly of the present invention would be to remove the assembly from its shipment package (not shown) and mount the blood bag on a suitable standard. The phlebotomy needle is then inserted in the donors vein and passage of the blood will proceed immediately through the feed tube 12 and directly into the blood bag 14.
It should be noted here that the packaged assembly will normally include a standard anti-coagulant in the blood bag and that during shipment, some of the anti-coagulant will possibly drain into the feed tube 12. However, with the initial in rush of blood through the tube 12, the anti-coagulant will be swept back into the blood bag 14 where it operates in its desired capacity to prevent coagulation of the donation during storage and shipment.
At this point, while in a sense the blood passing through the system has passed through the sample pouch, none of the blood is actually entered the pouch but rather it has flowed through the tubing 12 directly into the blood bag 14. The tubing 12 from its initial end to its terminal end is of a substantially constant diameter and it is essential that no abrupt changes in the diameter of the tubing be present. The substantially constant diameter of the tube 12 throughout its entire length insures a laminae flow of the blood from the donor to the bag 14 and avoids any turbulence in the flow which would tend to result in coagulation. This is particularly true when the blood is passing through the pouch 22 since in the initial use of the system, the pouch 22 acts merely to encapsulate the tubing 12 and the smooth flow of the blood through the pouch is uninterrupted during the period in which the donation is collected.
It should be noted that when the system is initially taken out of its shipment package, the bag, pouch and possibly the tubing will be collapsed and air will have been expelled from at least a major portion of the system. This condition of the system may be insured by either the construction of the bag and pouch to have basically a flat or sandwich type construction so that a minor amount of interior space will initially be presented, or, on the other hand, the system may be connected to a vacuum source and completely collapsed with a clamp placed on the feed tube 12 adjacent the initial end 16 and which clamp is removed only after the phlebotomy needle 16 has been inserted in the donors vein. The purpose of insuring that air is expelled from the system initially is to avoid the need for a vent port or the like to which air may escape when a volume of air that would otherwise be within the bag or pouch is displaced by the inrushing blood. If the bag is collapsed initially so as to avoid having any air in the chamber thereof, the flexible bag or pouch will deform in response to the incoming blood in order to provide a sufficient volume within its chamber to accomodate the donation and/or sample.
Once the donation has been collected, the blood bag 14 is isolated from the system by either providing a clamp on the segment of tube 28 or tying off the tube at the section 28 in any convenient manner. Next, the frangible portion 20 within the flexible pouch 22 is broken so as to place the passage of the tube 12 in communication with the chamber 30 formed interior of the sample pouch 22. Since the pouch 22 is sealed to the outside diameter of the tube 12 at points 24 and 26, the interior side walls of the pouch form a collection chamber surrounding the tubing in which may be collected a sample of the donation being offered. After the chamber 30 is filled, the section 32 of the tubing 12 is clamped or sealed off in any desired manner and the needle is removed from the donor. The sealed sample pouch is then removed from the system by cutting the tubing and a sample of the blood just collected is thus provided for testing purposes. This sample is exactly representative of the donation just collected and is obtained with a minimum of coagulation and at the same time contamination of the sample by any of the anti-coagulate in the system is prevented.
Referring now to FIGS. 2, 3 and 4, details of the frangible portion 20 are illustrated. In FIG. 2, the frangible portion 20 is shown as either a hardened or weakened segment 34 in the line of the tube 12 between the sections 32 and 28. Since the pouch 22 is of a flexible and preferably transparent material, once the blood bag 14 has been filled, it will merely be necessary to grasp the sections 28 and 32 and break the tube 12 at the point 34 in order to place the passage of the tube 12 in communication with the chamber 30.
Referring now to FIG. 3, the frangible portion 20 of this embodiment is shown to include a sleeve 40 connecting the two sections 28 and 32 of the tube 12. In this embodiment, when the bag 14 is filled, and after the section 28 has been clamped or sealed off to isolate the bag 14 from the system, it is merely necessary to flex the pouch so as to create some slack and then grasp the sections 28 and 32 and pull them axially, taking up the slack that had been created and thus freeing sections 28 and 32 of the sleeve 40. When either of the sections 28 and 32 are freed from the sleeve 40, the passage of the tube 12 is placed in communication with the chamber 30 and the sample of the donation may be collected.
Referring now to FIG. 4, another embodiment of the invention is shown in which the frangible portion 20 includes the relatively rigid sleeve 42. The sleeve 42 is counterbored at 44 and 46 for receiving the sections 32 and 28, respectively, of the tubing 12. The central portion 48 of the sleeve 42 is of the same inside diameter as the tube 12 and the counterbores 44 and 46 are of the same outside diameter as the tube 12 so that a substantially constant diameter passage is provided for the blood flowing from the donor to the bag 14 and laminae flow of the blood is insured. This laminae flow is also insured in the embodiment shown in FIGS. 2 and 3 due to the substantially constant inside diameter of the tubing as is apparent from the drawings.
The central portion 48 of the sleeve 42 is weakened at 50, and once the bag 14 has been filled and isolated from the system by the clamping procedure previously described, it is merely necessary to grasp the two ends of the sleeve 42 on either side of the central portion 48 and snap the frangible member at the point 50. This rupture of the sleeve 42 places the passage of the tube 12 in communication with the chamber 30 of the pouch 22 so that the sample may be collected.
The exemplary embodiments of the invention having been described, the true nature and scope of what is desired to be ins urled by letters patent is defined in the appended claims.
c arm:
1. In a blood collection assembly including a needle for inserting in a donors vein, a bag for collection of the donation, and tubing having an initial end and a terminal end, said tubing connected to said needle at said initial end and to said bag at said terminal end, the improvement comprising: said tubing having a passageway therethrough of substantially constant inside diameter from said initial end to said terminal end to insure laminar flow of blood through said tubing and avoid turbulent flow at any point along said passageway, said tubing having a frangible portion intermediate said initial and terminal ends, and a closed sample pouch encapsulating said frangible portion and having end walls sealed to said tubing on either side of said frangible portion, said pouch including an empty chamber formed about the continuous length of said tubing including said frangible portion, said frangible portion being disposed intermediate, but spaced from, said end walls.
2. The assembly as defined in claim 1 wherein said frangible portion is a hardened segment of said tubing.
3. The assembly as defined in claim 1 wherein said frangible portion is a weakened section of said tubing.
4. The assembly as defined in claim 1 wherein said tubing includes a first section communicating with said initial end and a second section communicating with said terminal end, and said frangible portion includes a sleeve holding said first and second sections of said tubing in abutting engagement.
5. The assembly as defined in claim 4 wherein said sleeve is flexible.
6. The assembly as defined in claim 4 wherein said sleeve is rigid.
7. The assembly as defined in claim 1 wherein said tubing includes a first section communicating with said initial end and a second section communication with said terminal end, said frangible portion includes a hardened sleeve having a weakened central section, counterbored end sections and shoulders interconnecting said central sections and said end sections, the inside diameter of the central section being substantially constant and equal to the inside diameter of said tubing, the inside diameter of said end sections being substantially equal to the outside diameter of said tubing and said first and second sections of said tubing fitted within said end sections and abutting said shoulders.
8. The assembly as defined in claim 1 wherein said bag contains an amount of anti-coagulant and said frangible portion is unbroken.
9. A method of collecting blood from a donor which includes placing tubing in communication with a donor source, passing blood through said tubing in a laminar flow pattern from said cource to a collection point, collecting a donation of blood at said collection point, interrupting said laminar flow pattern intermediate said source and said collection point, and collecting a sample of blood in a pouch having a first end wall sealed to the tubing upstream of the point of interruption of said flow pattern and a second end wall sealed to the tubing downstream of the point of interruption of said flow pattern said pouch having side walls surrounding said tubing to define a chamber for collecting the sample of blood.
10. The method as defined in claim 9 further including providing an anti-coagulant at said collection point prior to passing blood thereto.
11. The method as defined in claim 10 further including maintaining said chamber free from anti-coagulant solution.
12. The method as defined in claim 9 further including insuring said laminar flow pattern by providing the tubing with a substantially constant inside diameter between said source and said collection point and interrupting said flow pattern by breaking the tubing at a frangible portion thereof.

Claims (12)

1. In a blood collection assembly including a needle for inserting in a donor''s vein, a bag for collection of the donation, and tubing having an initial end and a terminal end, said tubing connected to said needle at said initial end and to said bag at said terminal end, the improvement comprising: said tubing having a passageway therethrough of substantially constant inside diameter from said initial end to said terminal end to insure laminar flow of blood through said tubing and avoid turbulent flow at any point along said passageway, said tubing having a frangible portion intermediate said initial and terminal ends, and a closed sample pouch encapsulating said frangible portion and having end walls sealed to said tubing on either side of said frangible portion, said pouch including an empty chamber formed about the continuous length of said tubing including said frangible portion, said frangible portion being disposed intermediate, but spaced from, said end walls.
2. The assembly as defined in claim 1 wherein said frangible portion is a hardened segment of said tubing.
3. The assembly as defined in claim 1 wherein said frangible portion is a weakened section of said tubing.
4. The assembly as defined in claim 1 wherein said tubing includes a first section communicating with said initial end and a second section communicating with said terminal end, and said frangible portion includes a sleeve holding said first and second sections of said tubing in abutting engagement.
5. The assembly as defined in claim 4 wherein said sleeve is flexible.
6. The assembly as defined in claim 4 wherein said sleeve is rigid.
7. The assembly as defined in claim 1 wherein said tubing includes a first section communicating with said initial end and a second section communication with said terminal end, said frangible portion includes a hardened sleeve having a weakened central section, counterbored end sections and shoulders interconnecting said central sections and said end sections, the inside diameter of the central section being substantially constant and equal to the inside diameter of said tubing, the inside diameter of said end sections being substantially equal tO the outside diameter of said tubing and said first and second sections of said tubing fitted within said end sections and abutting said shoulders.
8. The assembly as defined in claim 1 wherein said bag contains an amount of anti-coagulant and said frangible portion is unbroken.
9. A method of collecting blood from a donor which includes placing tubing in communication with a donor source, passing blood through said tubing in a laminar flow pattern from said cource to a collection point, collecting a donation of blood at said collection point, interrupting said laminar flow pattern intermediate said source and said collection point, and collecting a sample of blood in a pouch having a first end wall sealed to the tubing upstream of the point of interruption of said flow pattern and a second end wall sealed to the tubing downstream of the point of interruption of said flow pattern said pouch having side walls surrounding said tubing to define a chamber for collecting the sample of blood.
10. The method as defined in claim 9 further including providing an anti-coagulant at said collection point prior to passing blood thereto.
11. The method as defined in claim 10 further including maintaining said chamber free from anti-coagulant solution.
12. The method as defined in claim 9 further including insuring said laminar flow pattern by providing the tubing with a substantially constant inside diameter between said source and said collection point and interrupting said flow pattern by breaking the tubing at a frangible portion thereof.
US37205A 1970-05-14 1970-05-14 Blood collection assembly Expired - Lifetime US3654924A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3720570A 1970-05-14 1970-05-14

Publications (1)

Publication Number Publication Date
US3654924A true US3654924A (en) 1972-04-11

Family

ID=21893026

Family Applications (1)

Application Number Title Priority Date Filing Date
US37205A Expired - Lifetime US3654924A (en) 1970-05-14 1970-05-14 Blood collection assembly

Country Status (6)

Country Link
US (1) US3654924A (en)
BE (1) BE767209A (en)
DE (1) DE2123809A1 (en)
FR (1) FR2093497A5 (en)
GB (1) GB1297883A (en)
ZA (1) ZA712541B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007738A (en) * 1974-07-31 1977-02-15 Terumo Corporation Mechanism for allowing blood bags to communicate with each other
US4056101A (en) * 1976-09-01 1977-11-01 Baxter Travenol Laboratories, Inc. Means for reducing tissue thromboplastin in collected blood
US4943283A (en) * 1988-07-20 1990-07-24 City Of Hope Blood collecting apparatus with shielded needles
WO1992012684A1 (en) * 1991-01-22 1992-08-06 Baxter International Inc. Blood container having lay-flat sample reservoir
US5702383A (en) * 1994-07-01 1997-12-30 Baxter International Inc. Blood component collection systems and methods using an integral sampling device
US5772607A (en) * 1995-06-06 1998-06-30 The Nemours Foundation Body fluid collection apparatus
US5916202A (en) * 1996-08-30 1999-06-29 Haswell; John N. Umbilical cord blood collection
WO2001058507A3 (en) * 2000-02-14 2002-04-25 Menachem Kraus Predonation blood sampling apparatus
US6497669B1 (en) * 2001-06-04 2002-12-24 Rheologics, Inc. Non-biohazard blood letting system
US20030144607A1 (en) * 1999-07-29 2003-07-31 Jean-Marie Mathias Method and apparatus for collecting blood samples prior to a blood collection procedure
US20030176813A1 (en) * 1999-07-29 2003-09-18 Jean-Marie Mathias Biological fluid sampling apparatus
US6626884B1 (en) 1998-10-26 2003-09-30 Noble House Group Pty. Ltd. Sampling in blood collection
US20040082899A1 (en) * 1999-07-29 2004-04-29 Jean-Marie Mathias Biological fluid sampling apparatus
US20050148993A1 (en) * 1999-07-29 2005-07-07 Jean-Marie Mathias Method and apparatus for blood sampling

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950716A (en) * 1956-01-23 1960-08-30 Fenwal Lab Inc Fluid handling method and apparatus
US2955595A (en) * 1959-05-19 1960-10-11 Fenwal Lab Inc Therapeutic fluid sampling means
US3064647A (en) * 1957-06-13 1962-11-20 Baxter Laboratories Inc Blood component separation method and apparatus
US3127892A (en) * 1960-07-13 1964-04-07 Baxter Laboratories Inc Blood handling apparatus
US3217710A (en) * 1963-03-25 1965-11-16 Abbott Lab Blood collection and sampling apparatus provided with separable coupling means
US3342179A (en) * 1965-06-18 1967-09-19 Abbott Lab Blood collection and sampling apparatus having separable coupling means
US3467095A (en) * 1967-04-24 1969-09-16 Eugene Ross Lab Inc Blood collection set

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950716A (en) * 1956-01-23 1960-08-30 Fenwal Lab Inc Fluid handling method and apparatus
US3064647A (en) * 1957-06-13 1962-11-20 Baxter Laboratories Inc Blood component separation method and apparatus
US2955595A (en) * 1959-05-19 1960-10-11 Fenwal Lab Inc Therapeutic fluid sampling means
US3127892A (en) * 1960-07-13 1964-04-07 Baxter Laboratories Inc Blood handling apparatus
US3217710A (en) * 1963-03-25 1965-11-16 Abbott Lab Blood collection and sampling apparatus provided with separable coupling means
US3342179A (en) * 1965-06-18 1967-09-19 Abbott Lab Blood collection and sampling apparatus having separable coupling means
US3467095A (en) * 1967-04-24 1969-09-16 Eugene Ross Lab Inc Blood collection set

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007738A (en) * 1974-07-31 1977-02-15 Terumo Corporation Mechanism for allowing blood bags to communicate with each other
US4056101A (en) * 1976-09-01 1977-11-01 Baxter Travenol Laboratories, Inc. Means for reducing tissue thromboplastin in collected blood
US4943283A (en) * 1988-07-20 1990-07-24 City Of Hope Blood collecting apparatus with shielded needles
WO1992012684A1 (en) * 1991-01-22 1992-08-06 Baxter International Inc. Blood container having lay-flat sample reservoir
US5167656A (en) * 1991-01-22 1992-12-01 Baxter International Inc. Blood container having lay-flat sample reservoir
AU642080B2 (en) * 1991-01-22 1993-10-07 Baxter International Inc. Blood container having lay-flat sample reservoir
US5702383A (en) * 1994-07-01 1997-12-30 Baxter International Inc. Blood component collection systems and methods using an integral sampling device
US5772607A (en) * 1995-06-06 1998-06-30 The Nemours Foundation Body fluid collection apparatus
US5916202A (en) * 1996-08-30 1999-06-29 Haswell; John N. Umbilical cord blood collection
US6179819B1 (en) * 1996-08-30 2001-01-30 John N. Haswell Umbilical cord blood collection
US6626884B1 (en) 1998-10-26 2003-09-30 Noble House Group Pty. Ltd. Sampling in blood collection
US7479131B2 (en) 1999-07-29 2009-01-20 Fenwal, Inc. Biological fluid sampling apparatus, assembly and method
US20030144607A1 (en) * 1999-07-29 2003-07-31 Jean-Marie Mathias Method and apparatus for collecting blood samples prior to a blood collection procedure
US20030176813A1 (en) * 1999-07-29 2003-09-18 Jean-Marie Mathias Biological fluid sampling apparatus
US8079997B2 (en) 1999-07-29 2011-12-20 Fenwal, Inc. Apparatus for collecting blood samples
US7824343B2 (en) 1999-07-29 2010-11-02 Fenwal, Inc. Method and apparatus for blood sampling
US7699828B2 (en) * 1999-07-29 2010-04-20 Fenwal, Inc. Container for receiving a blood sample
US20040082899A1 (en) * 1999-07-29 2004-04-29 Jean-Marie Mathias Biological fluid sampling apparatus
US20050143712A1 (en) * 1999-07-29 2005-06-30 Jean-Marie Mathias Sampling tube holder for blood sampling system
US20050148993A1 (en) * 1999-07-29 2005-07-07 Jean-Marie Mathias Method and apparatus for blood sampling
US7044941B2 (en) 1999-07-29 2006-05-16 Baxter International Inc. Method and apparatus for collecting blood samples prior to a blood collection procedure
US20060111687A1 (en) * 1999-07-29 2006-05-25 Jean-Marie Mathias Sampling tube holder for blood sampling system
US20060111658A1 (en) * 1999-07-29 2006-05-25 Jean-Marie Mathias Sampling tube holder for blood sampling system
US20030208151A1 (en) * 2000-02-14 2003-11-06 Menachem Kraus Predonation blood sampling apparatus
US7087047B2 (en) 2000-02-14 2006-08-08 Teva Medical Ltd. Predonation blood sampling apparatus
US6692479B2 (en) 2000-02-14 2004-02-17 Teva Medical Ltd. Donor blood sampling system
WO2001058507A3 (en) * 2000-02-14 2002-04-25 Menachem Kraus Predonation blood sampling apparatus
US6497669B1 (en) * 2001-06-04 2002-12-24 Rheologics, Inc. Non-biohazard blood letting system

Also Published As

Publication number Publication date
BE767209A (en) 1971-11-16
DE2123809A1 (en) 1971-12-02
ZA712541B (en) 1972-01-26
GB1297883A (en) 1972-11-29
FR2093497A5 (en) 1972-01-28

Similar Documents

Publication Publication Date Title
US3654924A (en) Blood collection assembly
US5167656A (en) Blood container having lay-flat sample reservoir
US2950716A (en) Fluid handling method and apparatus
US2702034A (en) Apparatus for collecting, storing, and dispensing whole blood
EP0455215B1 (en) Blood collection device
US3127892A (en) Blood handling apparatus
US4381776A (en) Anticoagulant dispensing apparatus and method of use
US3640267A (en) Clinical sample container
US3276447A (en) Flexible tubing clamp
US3870042A (en) Apparatus for separating and injecting blood component
SE8402023L (en) blood bag
JPS59160466A (en) Cerebral liquid discharge apparatus
WO2016134317A1 (en) Composite liquid bag system holder
US4911696A (en) Branch tube
US3416528A (en) Blood handling equipment
US4195631A (en) Flow regulating device useable in plasma pheresis
CA1307211C (en) Tube assembly breakaway for openness
GB1126119A (en) Blood collection and sampling apparatus having separable coupling means
US4326518A (en) Separable integral donor connector with manual clamping means
EP0092528A1 (en) Endoperitoneal dialysis device
GB1591989A (en) Container containing blood
USRE25129E (en) Apparatus for collecting
US3485751A (en) Dialyzer apparatus and method
US20040182734A1 (en) Packaged bag system with identification tags
WO1989009025A1 (en) Blood collecting unit and its use